Adams Asset Advisors’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-842,900
Closed -$41K 88
2018
Q3
$41K Hold
842,900
﹤0.01% 100
2018
Q2
$244K Hold
842,900
0.03% 95
2018
Q1
$370K Buy
842,900
+261,000
+45% +$1.93M 0.05% 90
2017
Q4
$5.82M Buy
+581,900
New +$4.85M 0.72% 30

Other funds holding CLMT

Adams Asset Advisors's CLMT Position: Q2 2026 in Review

Adams Asset Advisors reduced its Calumet Specialty Products (CLMT) stake by 37% in Q2 2026, selling an estimated $40.2M and leaving 2,006,206 shares worth $72.3M. The position accounts for 8.2% of the portfolio, ranked #3.

Adams Asset Advisors first reported a position in CLMT in Q2 2013 and has held it in 53 quarters since. The position peaked at $116M in Q4 2024. 17 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Adams Asset Advisors held 2,006,206 shares of Calumet Specialty Products worth $72.3M as of Q2 2026.
  • Adams Asset Advisors sold 1,196,026 Calumet Specialty Products shares in Q2 2026, an estimated $40.2M.
  • Calumet Specialty Products made up 8.2% of Adams Asset Advisors's portfolio in Q2 2026, its #3 holding.
  • Adams Asset Advisors first reported a position in Calumet Specialty Products in Q2 2013 and has held it in 53 quarters since.
  • Adams Asset Advisors's Calumet Specialty Products position peaked at $116M in Q4 2024.
  • 17 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Adams Asset Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.